Our Client is seeking a highly motivated and team-oriented candidate for the
position of Scientist in the Drug Metabolism and Pharmacokinetics (DMPK)
Department. The successful applicant will lead the development, validation, and
application of cell based in vitro ADME assays to support our discovery and
development programs. Reporting directly to the Senior Director of Clin Pharm,
this is a unique opportunity to take on a role with a broad range of
responsibilities and work in DMPK and Clinical Pharmacology.
Core responsibilities:
Utilize animal models, define efficacy, pharmacodynamics and translational
principles for selection of development candidate molecules Conducts the
analysis, interpretation and reporting of clinical and non-clinical
pharmacokinetic data.
Helps plan, conducts and reports quantitative analyses to select / optimize
doses, dosage regimens throughout clinical drug development Experience with
Simcyp, Monolix, Phoenix Winnonlin or other modeling software. PBPK experience
and experience with DDI is crucial
Qualifications:
Must have 2+ years of experience in the pharma/ biotechnology industry or Post
Doc. Ph.D./PharmD in Pharmacology, Biomedical Sciences, Pharmacokinetics or
other discipline with appropriate experience Strong, demonstrable track record
of scientific leadership excellence Demonstrated small molecule drug discovery
experience: track-record of advancing multiple novel therapeutic agents from
discovery into preclinical and subsequent clinical development as project team
leader or member Experience in successfully selecting and managing CROs to
provide high quality, timely and on-budget studies
For more information please contact:
TJ Elder
Search Consultant
Pre-Clinical Development
O: 413.458.6124
C: 413.207.7676
https://www.linkedin.com/in/tjelder/
[email protected]<mailto:[email protected]>
[cid:[email http://www.stem-sourcing.com/
Please Note:
The information in this e-mail message is legally privileged and confidential
information intended only for the use of the addressee(s) named above. If you,
the reader of this message, are not the intended recipient, you are hereby
notified that you should not further disseminate, distribute, or forward this
e-mail message. If you have received this e-mail in error, please notify the
sender as soon as possible. In addition, please delete the erroneously
received message from any device/media where the message is stored.